NZ220926A - Tricyclic compounds and pharmaceutical compositions - Google Patents
Tricyclic compounds and pharmaceutical compositionsInfo
- Publication number
- NZ220926A NZ220926A NZ220926A NZ22092687A NZ220926A NZ 220926 A NZ220926 A NZ 220926A NZ 220926 A NZ220926 A NZ 220926A NZ 22092687 A NZ22092687 A NZ 22092687A NZ 220926 A NZ220926 A NZ 220926A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- tricyclic compounds
- tricyclic
- compounds
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8609681A FR2601011B1 (fr) | 1986-07-03 | 1986-07-03 | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ220926A true NZ220926A (en) | 1989-11-28 |
Family
ID=9337042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ220926A NZ220926A (en) | 1986-07-03 | 1987-07-02 | Tricyclic compounds and pharmaceutical compositions |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4977152A (da) |
| EP (1) | EP0251937B1 (da) |
| JP (1) | JPH029866A (da) |
| KR (1) | KR880001614A (da) |
| AR (1) | AR245123A1 (da) |
| AT (1) | ATE60589T1 (da) |
| AU (1) | AU602339B2 (da) |
| CA (1) | CA1312864C (da) |
| DE (1) | DE3767794D1 (da) |
| DK (1) | DK162220C (da) |
| ES (1) | ES2039256T3 (da) |
| FR (1) | FR2601011B1 (da) |
| GR (1) | GR3001646T3 (da) |
| NZ (1) | NZ220926A (da) |
| PT (1) | PT85234B (da) |
| ZA (1) | ZA874846B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2625201B1 (fr) * | 1987-12-24 | 1990-06-15 | Sanofi Sa | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant |
| US4985560A (en) * | 1990-01-12 | 1991-01-15 | American Home Products Corporation | Pyridazino(4,5-b)indolizines |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| US20030176437A1 (en) * | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| KR100422589B1 (ko) * | 2001-11-20 | 2004-03-16 | (주)경인양행 | 셀룰로오스 섬유 또는 셀룰로오스 혼방섬유의 염색 방법 |
| EP2592075B1 (en) | 2004-11-02 | 2015-04-29 | Northwestern University | Pyridazine compounds for the treatment of inflammatory diseases |
| CA2589102C (en) * | 2004-11-02 | 2013-08-13 | Northwestern University | Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| US20090325973A1 (en) * | 2006-04-28 | 2009-12-31 | Watterson D Martin | Formulations containing pyridazine compounds |
| EP2015751A2 (en) * | 2006-04-28 | 2009-01-21 | Northwestern University | Salts of pyridazine compounds |
| EP2015750A2 (en) * | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| AU2009204147A1 (en) * | 2008-01-07 | 2009-07-16 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
| FR2619818B1 (fr) * | 1987-09-01 | 1990-01-12 | Sanofi Sa | Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
-
1986
- 1986-07-03 FR FR8609681A patent/FR2601011B1/fr not_active Expired
-
1987
- 1987-07-02 DK DK340987A patent/DK162220C/da not_active IP Right Cessation
- 1987-07-02 AU AU75049/87A patent/AU602339B2/en not_active Ceased
- 1987-07-02 NZ NZ220926A patent/NZ220926A/xx unknown
- 1987-07-02 PT PT85234A patent/PT85234B/pt not_active IP Right Cessation
- 1987-07-02 AR AR87308037A patent/AR245123A1/es active
- 1987-07-02 CA CA000541127A patent/CA1312864C/en not_active Expired - Fee Related
- 1987-07-03 DE DE8787401562T patent/DE3767794D1/de not_active Expired - Fee Related
- 1987-07-03 AT AT87401562T patent/ATE60589T1/de not_active IP Right Cessation
- 1987-07-03 JP JP62166746A patent/JPH029866A/ja active Pending
- 1987-07-03 KR KR1019870007113A patent/KR880001614A/ko not_active Application Discontinuation
- 1987-07-03 ES ES198787401562T patent/ES2039256T3/es not_active Expired - Lifetime
- 1987-07-03 ZA ZA874846A patent/ZA874846B/xx unknown
- 1987-07-03 EP EP87401562A patent/EP0251937B1/fr not_active Expired - Lifetime
-
1990
- 1990-01-25 US US07/471,680 patent/US4977152A/en not_active Expired - Fee Related
-
1991
- 1991-03-21 GR GR91400356T patent/GR3001646T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3001646T3 (en) | 1992-11-23 |
| DE3767794D1 (de) | 1991-03-07 |
| AU7504987A (en) | 1988-01-07 |
| ZA874846B (en) | 1988-03-30 |
| ATE60589T1 (de) | 1991-02-15 |
| JPH029866A (ja) | 1990-01-12 |
| AU602339B2 (en) | 1990-10-11 |
| DK162220C (da) | 1992-03-02 |
| PT85234B (pt) | 1990-04-30 |
| EP0251937B1 (fr) | 1991-01-30 |
| US4977152A (en) | 1990-12-11 |
| ES2039256T3 (es) | 1993-09-16 |
| FR2601011B1 (fr) | 1988-10-28 |
| CA1312864C (en) | 1993-01-19 |
| PT85234A (fr) | 1987-08-01 |
| KR880001614A (ko) | 1988-04-25 |
| DK162220B (da) | 1991-09-30 |
| AR245123A1 (es) | 1993-12-30 |
| DK340987A (da) | 1988-01-04 |
| DK340987D0 (da) | 1987-07-02 |
| EP0251937A1 (fr) | 1988-01-07 |
| FR2601011A1 (fr) | 1988-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2196964B (en) | Pharmaceutical compositions | |
| NZ222980A (en) | 3-aryloxy-3-substituted propanamines and pharmaceutical compositions | |
| NZ223096A (en) | Peptidylaminodiols and pharmaceutical compositions | |
| GB8613688D0 (en) | Pharmaceutical composition | |
| GB8708659D0 (en) | Pharmaceutical composition | |
| NZ226002A (en) | Peptidylheterocyclic compounds and pharmaceutical compositions | |
| GB8608818D0 (en) | Pharmaceutical compositions | |
| NZ220650A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
| GB8618259D0 (en) | Pharmaceutical compositions | |
| GB2191696B (en) | Pharmaceutical compositions | |
| NZ220176A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
| GB2190838B (en) | Pharmaceutical compositions | |
| NZ220926A (en) | Tricyclic compounds and pharmaceutical compositions | |
| GB8713632D0 (en) | Oculistics pharmaceutical composition | |
| GB8628373D0 (en) | Pharmaceutical composition | |
| GB2188235B (en) | Pharmaceutical compositions | |
| NZ219748A (en) | Indenopyrimidines and pharmaceutical compositions | |
| GB8709166D0 (en) | Pharmaceutical composition | |
| GB8620073D0 (en) | Pharmaceutical compositions | |
| GB8621756D0 (en) | Pharmaceutical compositions | |
| GB8614189D0 (en) | Pharmaceutical composition | |
| GB8719913D0 (en) | Pharmaceutical composition | |
| GB8706824D0 (en) | Pharmaceutical composition | |
| GB8615041D0 (en) | Pharmaceutical compositions | |
| GB8704660D0 (en) | Pharmaceutical composition |